In summary, biopsy of suspicious lesions can confirm the relapse of the tumor, exclude the second primary tumor, identify the status of ER, PR and HER2, and allow some patients with breast cancer to benefit from hormone therapy and/or anti-HER2 treatment. Here, ERBB2 is linked to neoplasm.